Mon, October 12, 2020

Raghuram Selvaraju Maintained (BBIO) at Strong Buy with Increased Target to $53 on, Oct 12th, 2020

Raghuram Selvaraju of HC Wainwright & Co., Maintained "BridgeBio Pharma, Inc." (BBIO) at Strong Buy with Increased Target from $50 to $53 on, Oct 12th, 2020.

Raghuram has made no other calls on BBIO in the last 4 months.



There is 1 other peer that has a rating on BBIO. Out of the 1 peers that are also analyzing BBIO, all agrees with Raghuram's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoff Meacham of "B of A Securities" Initiated at Hold and Held Target at $38 on, Thursday, June 25th, 2020